Lundbeck Canada Inc. v. Canada (Minister of Health) et al., (2009) 343 F.T.R. 53 (FC)

This document cites

• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., 2005 FC 390
• Janssen-Ortho Inc. et al. v. Novopharm Ltd. et al., (2004) 264 F.T.R. 202 (FC)
• Kent Trade and Finance Inc. et al. v. JPMorgan Chase Bank et al., 2008 FCA 399
• Biovail Pharmaceuticals Inc. et al. v. Canada (Minister of National Health and Welfare) et al., 2005 FC 9



See all quotations

• Merck & Co. et al. v. Apotex Inc. et al., (2004) 253 F.T.R. 178 (FC)
• Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
• Sanofi-Aventis Inc. et al. v. Laboratoire Riva Inc. et al., 2007 FC 532
• Whirlpool Corp. et al. v. Camco Inc. et al., (2000) 263 N.R. 88 (SCC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2006) 358 N.R. 135 (FCA)
• Laboratoires Servier et al. v. Apotex Inc. et al., (2008) 332 F.T.R. 193 (FC)
• Ferring Inc. v. Canada (Minister of Health) et al., (2007) 310 F.T.R. 185 (FC)
• Minister of Employment and Immigration v. Satiacum, (1989) 99 N.R. 171 (FCA)
• Howe v. Canada (Attorney General) et al., (2007) 383 N.R. 397 (Motion)
• Free World Trust v. Électro Santé Inc. et al., (2000) 263 N.R. 150 (SCC)
• Merck Frosst Canada Inc. et al. v. Canada (Minister of National Health and Welfare) et al., (1998) 227 N.R. 299 (SCC)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2005) 285 F.T.R. 1 (FC)
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., 2008 FC 593
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., (2007) 319 F.T.R. 48 (FC)
• Sanofi-Aventis Canada Inc. v. Novopharm Ltd. et al., (2007) 364 N.R. 325 (FCA)
• Burton Parson Chemicals Inc. et al. v. Hewlett-Packard (Canada) Ltd. et al., (1974) 3 N.R. 553 (SCC)
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., 2007 FCA 217
• Atlantic Engraving Ltd. v. Rosenstein, (2002) 299 N.R. 244 (FCA)
• Pioneer Hi-Bred Ltd. v. Commissioner of Patents, (1989) 97 N.R. 185 (SCC)
• Merrell Dow Pharmaceuticals Inc. et al. v. Norton (H.N.) & Co. et al., (1995) 189 N.R. 364 (HL)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2008 FC 1359
• Janssen-Ortho Inc. et al. v. Novopharm Ltd., (2006) 301 F.T.R. 166 (FC)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., 2008 FCA 108
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2009 FCA 8
• Apotex Inc. v. Sanofi-Synthelabo Canada Inc., [2008] 3 SCR 265
• Free World Trust v. Électro Santé Inc., [2000] 2 SCR 1024